169 related articles for article (PubMed ID: 34627453)
1. [Clinical Characteristics, Prognostic Factors and Misdiagnosis of Bone Marrow Necrosis Patients].
Lin CQ; Yang Y; Mao H; Zhao Q; Wu JQ; Li DP; Huang YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1637-1644. PubMed ID: 34627453
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature.
Paydas S; Ergin M; Baslamisli F; Yavuz S; Zorludemir S; Sahin B; Bolat FA
Am J Hematol; 2002 Aug; 70(4):300-5. PubMed ID: 12210811
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow necrosis secondary to metastatic adenocarcinoma revealed by 18F-FDG PET/CT: A clinical case report.
Dong P; Tian R; Li L; Su M
Medicine (Baltimore); 2017 Dec; 96(49):e9067. PubMed ID: 29245317
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
6. [Philadelphia chromosome-positive acute lymphoblastic leukemia complicated by bone marrow necrosis during consolidation chemotherapy].
Ishitsuka K; Obara N; Suyama T; Matsuoka R; Maruyama Y; Sakamoto T; Kusakabe M; Kato T; Kurita N; Nishikii H; Yokoyama Y; Sakata-Yanagimoto M; Hasegawa Y; Shinagawa A; Chiba S
Rinsho Ketsueki; 2020; 61(5):462-467. PubMed ID: 32507809
[TBL] [Abstract][Full Text] [Related]
7. Analysis and Clinical Characteristics of 23 Cases of Bone Marrow Necrosis.
Chen R; Wu J; Yang J; Wei C; Liang D; Du J; Li Y; Liu Q; Zhang Y; Deng L
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e356-e364. PubMed ID: 33541793
[TBL] [Abstract][Full Text] [Related]
8. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
9. Metastatic Neuroendocrine Tumor with Extensive Bone Marrow Involvement at Diagnosis: Evaluation of Response and Hematological Toxicity Profile of PRRT with (177)Lu-DOTATATE.
Basu S; Ranade R; Thapa P
World J Nucl Med; 2016; 15(1):38-43. PubMed ID: 26912977
[TBL] [Abstract][Full Text] [Related]
10. A case of bone marrow necrosis of an idiopathic aetiology: the report of a rare entity with review of the literature.
Bhasin TS; Sharma S; Chandey M; Bhatia PK; Mannan R
J Clin Diagn Res; 2013 Mar; 7(3):525-8. PubMed ID: 23634411
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow necrosis with dyspnea in a patient with malignant lymphoma and plasma levels of thrombomodulin, tumor necrosis factor-alpha, and D-dimer.
Seki Y; Koike T; Yano M; Aoki S; Hiratsuka M; Fuse I; Aizawa Y
Am J Hematol; 2002 Jul; 70(3):250-3. PubMed ID: 12111773
[TBL] [Abstract][Full Text] [Related]
12. Two cases of follicular lymphoma with MYC gene abnormalities that presented with bone marrow necrosis.
Miyazawa Y; Takei H; Kobayashi N; Akashi N; Sairenji Y; Sugisaki M; Naito C; Ishikawa T; Shimizu H; Ishizaki T; Yokohama A; Tsukamoto N; Yoshida Y; Matsumura N; Takayama Y; Handa H
J Clin Exp Hematop; 2022 Dec; 62(4):208-216. PubMed ID: 36261333
[TBL] [Abstract][Full Text] [Related]
13. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.
Lawrence JB; Friedman BS; Travis WD; Chinchilli VM; Metcalfe DD; Gralnick HR
Am J Med; 1991 Dec; 91(6):612-24. PubMed ID: 1750431
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow necrosis in malignant diseases. A report on seven intravitally recognized cases.
Scudla V; Dusek J; Macák J; Zivná J; Myslivecek M; Indrák K
Neoplasma; 1989; 36(5):603-10. PubMed ID: 2812154
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and cytomorphological features of bone marrow metastasis of non-hematological malignant carcinoma].
Li L; Cong Y; Cai L; Deng X; Guan J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Oct; 34(10):1541-5. PubMed ID: 25345959
[TBL] [Abstract][Full Text] [Related]
16. Disseminated focal
Horvath L; Seeber A; Uprimny C; Wolf D; Nachbaur D; Kocher F
Ther Adv Hematol; 2020; 11():2040620720977613. PubMed ID: 33425313
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow necrosis in acute leukemia: Clinical characteristic and outcome.
Badar T; Shetty A; Bueso-Ramos C; Cortes J; Konopleva M; Borthakur G; Pierce S; Huang X; Chen HC; Kadia T; Daver N; Dinardo C; O'Brien S; Garcia-Manero G; Kantarjian H; Ravandi F
Am J Hematol; 2015 Sep; 90(9):769-73. PubMed ID: 26017166
[TBL] [Abstract][Full Text] [Related]
18.
Li H; Xu C; Xin B; Zheng C; Zhao Y; Hao K; Wang Q; Wahl RL; Wang X; Zhou Y
Theranostics; 2019; 9(16):4730-4739. PubMed ID: 31367253
[No Abstract] [Full Text] [Related]
19. Recurrence of Acute Lymphoblastic Leukemia with Bone Marrow Necrosis: A Case Report and Review of the Literature on the MRI Features of Bone Marrow Necrosis.
Harada N; Nishimoto M; Ikemoto A; Okamura H; Koh S; Nanno S; Nakashima Y; Koh H; Nakane T; Kuwae Y; Ohsawa M; Hino M; Nakamae H
Intern Med; 2021 Apr; 60(7):1083-1088. PubMed ID: 33116012
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic value of bone marrow (18)F-FDG uptake pattern of pretreatment PET-CT in extranodal NK/T cell lymphoma].
Zhang Y; Zhou J; Wang L; Li JY; Ding CY
Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):885-890. PubMed ID: 33113633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
